Endoscopic Single Port Surgical Robot Market Report 2026

The endoscopic single port surgical robot market size has grown exponentially in recent years. It will grow from $1.2 billion in 2025 to $1.54 billion in 2026 at a compound annual growth rate (CAGR) of 28.5%. The growth in the historic period can be attributed to increasing adoption of minimally invasive surgeries, growing awareness about surgical precision, rising healthcare infrastructure development, expansion of robotic surgery training programs, increasing chronic disease surgical cases.

The endoscopic single port surgical robot market size is expected to see exponential growth in the next few years. It will grow to $4.16 billion in 2030 at a compound annual growth rate (CAGR) of 28.2%. The growth in the forecast period can be attributed to rising investment in healthcare robotics technology, growing integration of artificial intelligence and imaging technologies, increasing government support and funding for medical technology, rising demand for faster patient recovery, expansion of advanced surgical hospitals and centers. Major trends in the forecast period include advancement in single-port robotic instrument design, increasing tele-robotic surgery applications, growing use of augmented reality in surgery, rising focus on patient-centric surgical outcomes, expansion of cloud-connected surgical data platforms.

The growing adoption of minimally invasive surgeries is expected to drive the growth of the endoscopic single-port surgical robot market in the coming years. Minimally invasive surgeries are procedures performed through small incisions or a single access point, which reduce patient trauma, shorten recovery time, and lower the risk of complications. The use of minimally invasive techniques is increasing as hospitals and patients place greater emphasis on faster recovery, reduced postoperative pain, fewer complications, and minimal scarring compared with conventional open surgeries. Endoscopic single-port surgical robots support minimally invasive procedures by offering robotic-assisted platforms that deliver precise instrument control, three-dimensional visualization, and ergonomic operation within confined surgical spaces. For example, in June 2024, according to the American Society of Plastic Surgeons, a US-based nonprofit organization, minimally invasive procedures increased by 7% in 2023, exceeding the growth rate of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger procedures, reached 207,887 cases, reflecting a 2% increase from 2022. As a result, the rising adoption of minimally invasive surgeries is contributing to the expansion of the endoscopic single-port surgical robot market.

The increasing use of robot-assisted surgical technologies is also expected to propel the growth of the endoscopic single-port surgical robot market going forward. Artificial intelligence and robot-assisted surgical technologies involve advanced systems that combine AI capabilities with robotic mechanisms to help surgeons perform complex procedures with greater precision, control, and efficiency. Adoption of these technologies is accelerating as healthcare providers seek improved surgical accuracy, reduced complication rates, and faster patient recovery through minimally invasive and digitally guided procedures. Endoscopic single-port surgical robots support robot-assisted surgery by enabling precise, minimally invasive interventions through a single access point. They enhance patient outcomes by minimizing surgical trauma, shortening recovery periods, and improving procedural accuracy. For instance, in November 2024, according to the Private Healthcare Information Network, a UK-based government-mandated organization, approximately 22,700 robot-assisted procedures were performed in the first quarter of 2024, representing a 45% increase compared with the first quarter of 2023 and a 12% rise from the previous quarter. Consequently, the growing adoption of robot-assisted surgical technologies is driving the growth of the endoscopic single-port surgical robot market.

Major companies operating in the endoscopic single-port surgical robot market are concentrating on the development of advanced solutions, including single-port systems, to improve surgical precision, enhance patient safety, and minimize surgical invasiveness and recovery time. Single-port systems are robotic platforms that enable surgeons to operate multiple articulating instruments and a camera through a single, narrow access point within the body. For example, in May 2025, Intuitive Surgical Inc., a US-based medical technology company, obtained FDA clearance for its da Vinci Single Port (SP) system for transanal local excision and resection procedures in colorectal surgery. The da Vinci SP system is designed to navigate confined anatomical spaces, allowing surgeons to control up to three multi-jointed instruments along with a high-definition camera through a single entry point in the rectum. This approach addresses limitations of traditional techniques, such as ergonomic challenges and difficulty accessing upper rectal lesions, while enabling tissue dissection and removal through a natural orifice, thereby avoiding external scarring.

Major companies operating in the endoscopic single port surgical robot market are Johnson & Johnson, Medtronic Plc, Stryker Corporation, Smith & Nephew Plc, Zimmer Biomet Holdings Inc., Intuitive Surgical Operations Inc., Southcoast Health System Inc., Renishaw plc, Meerecompany Inc., Avatera Medical GmbH, CMR Surgical Ltd., Augmedics, Distalmotion SA, Think Surgical Inc., Titan Medical Inc., Proprio, Virtual Incision Corp., Wego Medical International Co. Ltd., Medivis, Asensus Surgical, Medicaroid Corporation, Shenzhen Edge Medical.

North America was the largest region in the endoscopic single port surgical robot market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic single port surgical robot market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endoscopic single port surgical robot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the endoscopic single-port surgical robot market by increasing costs of imported robotic components and precision instruments, causing delays in supply chains across key manufacturing regions such as asia-pacific. high tariffs particularly affect hardware segments like robotic arms and camera systems, as well as software integration tools. while the increased costs may slow adoption in certain hospitals and clinics, tariffs also encourage local production and innovation, potentially driving cost-optimized solutions and boosting domestic manufacturing capabilities.

Endoscopic single-port surgical robots are advanced robotic systems developed to carry out minimally invasive surgical procedures through a single small incision. They combine robotic arms, high-definition visualization, and precise instrument control to support surgeons during complex operations. These systems help improve surgical precision, minimize patient trauma, and reduce recovery time.

The main component types of endoscopic single-port surgical robots are hardware, software, and services. Hardware includes robotic arms, control units, visualization systems, and surgical tools designed to perform minimally invasive single-port operations with greater accuracy and dexterity. These systems use technologies such as robot-assisted surgery, conventional laparoscopic surgery, natural orifice transluminal endoscopic surgery, and teleoperated surgery. They are distributed through direct sales, distributors, and online platforms and used in bariatric, gynecological, urological, thoracic, general, and cardiothoracic surgeries among end users such as hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutions.

The endoscopic single-port surgical robots market consists of revenues earned by entities by providing services such as robotic-assisted surgical procedures, preoperative planning support, intraoperative guidance, postoperative monitoring, surgeon training and simulation, system installation, and technical maintenance and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The endoscopic single-port surgical robots market also includes sales of single-port robotic surgical systems, robotic arms and instruments, control consoles, endoscopic imaging devices, and integrated software platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.